Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...
Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to ...
GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and ...
GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB , a company discovering and developing novel ...
The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.
Beckley Psytech has completed subject enrolment for the core stage of the global Phase IIb clinical trial of patent-protected ...
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
Q4 2024 Earnings Call Transcript February 28, 2025 Longeveron Inc. beats earnings expectations. Reported EPS is $1.16, ...
Additional finalized Phase IIa clinical trials with vafidemstat include the ETHERAL ... randomized, double blind Phase IIb PORTICO trial (final data presented at ECNP-2024). Following receipt of the ...
CAIRO, March 2 (Reuters) - Hamas will not agree to extend the first phase of the Gaza ceasefire deal as requested by Israel, a senior Hamas official said Sunday. Speaking to Al Jazeera ...
CAIRO (AP) — Israel’s government said early Sunday it supports a proposal to extend the first phase of the ceasefire in Gaza through Ramadan and Passover, though Hamas has insisted on ...